Jesse S. Boehm

42.2k total citations · 3 hit papers
51 papers, 4.3k citations indexed

About

Jesse S. Boehm is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jesse S. Boehm has authored 51 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Jesse S. Boehm's work include Cancer Genomics and Diagnostics (17 papers), CRISPR and Genetic Engineering (7 papers) and Cancer Cells and Metastasis (6 papers). Jesse S. Boehm is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), CRISPR and Genetic Engineering (7 papers) and Cancer Cells and Metastasis (6 papers). Jesse S. Boehm collaborates with scholars based in United States, Germany and United Kingdom. Jesse S. Boehm's co-authors include William C. Hahn, Yuen‐Yi Tseng, Todd R. Golub, James M. McFarland, David E. Root, Francisca Vázquez, Rameen Beroukhim, Aviad Tsherniak, Gavin Ha and Bang Wong and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jesse S. Boehm

51 papers receiving 4.2k citations

Hit Papers

A GPX4-dependent cancer cell state underlies the clear-ce... 2017 2026 2020 2023 2019 2017 2021 200 400 600

Peers

Jesse S. Boehm
Mark R. Lackner United States
Simon Pacey United Kingdom
Crispin Miller United Kingdom
Christine M. Fillmore United States
George N. Naumov United States
Charles Massie United Kingdom
Mark R. Lackner United States
Jesse S. Boehm
Citations per year, relative to Jesse S. Boehm Jesse S. Boehm (= 1×) peers Mark R. Lackner

Countries citing papers authored by Jesse S. Boehm

Since Specialization
Citations

This map shows the geographic impact of Jesse S. Boehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse S. Boehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse S. Boehm more than expected).

Fields of papers citing papers by Jesse S. Boehm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse S. Boehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse S. Boehm. The network helps show where Jesse S. Boehm may publish in the future.

Co-authorship network of co-authors of Jesse S. Boehm

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse S. Boehm. A scholar is included among the top collaborators of Jesse S. Boehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse S. Boehm. Jesse S. Boehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boehm, Jesse S. & Tyler Jacks. (2024). Radical Collaboration: Reimagining Cancer Team Science. Cancer Discovery. 14(4). 563–568. 1 indexed citations
2.
Misek, Sean A., Jérémie Kalfon, Javad Noorbakhsh, et al.. (2024). Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries. Nature Communications. 15(1). 4892–4892. 4 indexed citations
3.
Krill-Burger, John M., Joshua M. Dempster, Ashir A. Borah, et al.. (2023). Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome biology. 24(1). 192–192. 13 indexed citations
4.
Warren, Allison, Andrew Jones, Tsukasa Shibue, et al.. (2021). Global computational alignment of tumor and cell line transcriptional profiles. Nature Communications. 12(1). 22–22. 72 indexed citations
5.
Doron, Shira, Robin R. Ingalls, Jesse S. Boehm, et al.. (2021). Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning. Cell Reports Medicine. 2(11). 100452–100452. 18 indexed citations
6.
Guenther, Lillian M., Neekesh V. Dharia, Linda S. Ross, et al.. (2018). A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma. Clinical Cancer Research. 25(4). 1343–1357. 62 indexed citations
7.
Rohban, Mohammad Hossein, Shantanu Singh, Xiaoyun Wu, et al.. (2017). Systematic morphological profiling of human gene and allele function via Cell Painting. eLife. 6. 97 indexed citations
8.
Giannikou, Krinio, Izabela A. Malinowska, Trevor J. Pugh, et al.. (2016). Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. PLoS Genetics. 12(8). e1006242–e1006242. 85 indexed citations
9.
Howard, Thomas P., Francisca Vázquez, Aviad Tsherniak, et al.. (2016). Functional Genomic Characterization of Cancer Genomes. Cold Spring Harbor Symposia on Quantitative Biology. 81. 237–246. 13 indexed citations
10.
Rosenbluh, Joseph, Yashaswi Shrestha, Rachel A. Oliver, et al.. (2016). Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers. Cell Systems. 3(3). 302–316.e4. 47 indexed citations
11.
Ren, Yin, Hiu Wing Cheung, Amit Agrawal, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4. Science Translational Medicine. 4(147). 147ra112–147ra112. 134 indexed citations
12.
Ren, Yin, Amit Agrawal, Jill P. Mesirov, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
13.
Cheung, Hiu Wing, Jinyan Du, Jesse S. Boehm, et al.. (2011). Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers. Cancer Discovery. 1(7). 608–625. 110 indexed citations
14.
Shrestha, Yashaswi, Eric J. Schafer, Jesse S. Boehm, et al.. (2011). PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 31(29). 3397–3408. 124 indexed citations
15.
McClelland, Verity M., Thomas Cullup, István Bódi, et al.. (2010). Vici syndrome associated with sensorineural hearing loss and evidence of neuromuscular involvement on muscle biopsy. American Journal of Medical Genetics Part A. 152A(3). 741–747. 35 indexed citations
16.
Kim, So Young, Ian F. Dunn, Ron Firestein, et al.. (2010). CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity. PLoS ONE. 5(2). e8979–e8979. 66 indexed citations
17.
Scholl, Claudia, Stefan Fröhling, Ian F. Dunn, et al.. (2009). Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells. Cell. 137(5). 821–834. 416 indexed citations
18.
Boehm, Jesse S.. (2007). Best of the web in pathology: a practical guide to finding specific pathology resources on the internet. Journal of Clinical Pathology. 61(2). 225–232. 3 indexed citations
19.
Boehm, Jesse S. & William C. Hahn. (2005). Cancer genetics: Finding the right mix. European Journal of Human Genetics. 13(10). 1099–1100. 2 indexed citations
20.
Boehm, Jesse S.. (2001). Regulation of BOB.1/OBF.1 stability by SIAH. The EMBO Journal. 20(15). 4153–4162. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026